Exane Derivatives Sol Gel Technologies Ltd. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Exane Derivatives holds 61 shares of SLGL stock, worth $26. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 61
-0.0%
Holding current value
$26
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
5.35MCall Options Held
1.5KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.09 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$540,1210.01% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$404,9460.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$100,8380.03% of portfolio
-
Prosperity Wealth Management, Inc. San Ramon, CA163KShares$71,8960.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $10.2M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...